Moreover, flow cytometric analysis and IHC staining revealed that cotreatment with αPD-L1 significantly increased the number and activation of tumor-infiltrating cytotoxic CD8 + T cells in the mice (Fig. 5i-l). The gene discussed is CD8A; the disease is neoplasm.